Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Smith

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Hepatology Communications|May 8, 2019
Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin TherapySehee Kim, Jeffrey Moore, Estella Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 1Thien Duc Tran, Florian Wakenhut, Chris Pickford, et al.
Nature Nanotechnology|May 23, 2024
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cellsXizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Journal of Medicinal Chemistry|September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitorsJames J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2017
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic FibrosisRobert P Howlin, Katrina Cathie, Luanne Hall-Stoodley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Hepatology Communications|May 8, 2019
Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin TherapySehee Kim, Jeffrey Moore, Estella Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 1Thien Duc Tran, Florian Wakenhut, Chris Pickford, et al.
Nature Nanotechnology|May 23, 2024
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cellsXizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Journal of Medicinal Chemistry|September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitorsJames J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2017
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic FibrosisRobert P Howlin, Katrina Cathie, Luanne Hall-Stoodley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Pageof 18